Equality Impact Assessments Dated Between August 2012 November

Equality Impact Assessments dated between August 2012 – November

2013

• Policy or service being assessed: Neonatal Antimicrobial Policy

• Trust Policy for the safe use of McKinley T34 syringe pump in adult palliative/oncology patients

• Policy for use of drugs used outside the terms of their product licence - 'Off label' Prescribing

• Policy for supply of Payment by Results (PBR) excluded drugs

• Policy for New Drug / Product Request

• Trust Guideline for Management of Neutropenia in Adults who had Systemic Anti-Cancer Therapy

• Guideline for Antimicrobial Agents in Adults (Antibiotic Guideline)

• Policy for the safe preparation of Ganciclovir at ward level

• Policy for supply of blood products from pharmacy

• Policy for the control of FP10(HP) prescriptions in clinic

Trust Policy Meticilin Resistant Staphylococcus Aureus

Trust Policy for Medicines Reconciliation on Admission of Adults to Hospital

• Trust Policy for the Prevention of IV Related Infections

• Policy for Neonatal central line positions

• Policy for newborn examinations

• Policy or service being assessed: Transitional Care of newborns

• Policy or service being assessed: Management of Enteral Tubes

• Policy or service being assessed: Antimicrobial policy in neonates

• Trustguideline for the management of hypoglycaemia in adults with diabetes mellitus

• Trust Policy for Standards for Oral Anticoagulants (OAs), Vitamin K Antagonists (VKAs)

• Trust Policy for Prescription Charts / Forms

• Trust Guideline for The Management of Human Infestations

Trust Guidelinefor the Management and Control of Viral Haemorrhagic Fevers

Trust Policy for Last Offices for Infected Patients

Trust Policy for Transmissible Spongiform Encephalopathy (TSE)

• Trust Policy for covert administration of medicinesfor adult patients

Trust Guideline for Meningococcal Infection (Meningitis and Septicaemia)

Trust Guideline for Infection Control Measures for Patients with Severe Acute Respiratory Syndrome (SARS)

• Trust Policy forthe use of potassium chloride injection and intravenous potassium replacement in adults

• Policy or service being assessed: Management of Infants Requiring Parental Nutrition

Trust Policy for Specimen Collection for Microbiological Analysis

• Trust Guideline for use of subcutaneous Metoject (Methotrexate) shared care guideline for adults who are competent to self-administer

Trust Policy forInfection Prevention & Control in the Operating Theatre

Trust Policy for the Management of Outbreaks of Infection inc. Major Outbreaks

Trust Policy for supply of medicinal products in prepacks or GSL packs to patients directly from wards and departments by non-pharmacy staff.

• Trust Guideline for The Management of Patients
  with an Absent or Dysfunctional Spleen

Trust Guideline for the assessment and management of Acute Kidney Injury (AKI) in Adults

• Trust Policy for Infection Prevention & Control Procedure for In-Patients with Gastro-Intestinal Infection Including Norovirus Outbreaks

• Trust Policy for Management of Linen

• Trust Guideline for Parenteral Nutrition in Adults

• Trust Policy for Glycopeptide Resistant Enterococci (Gre) Including Vancomycin Resistant Enterococci (Vre)

• Trust Policy for Ward Kitchens and Appliances

• Trust policy for Antibiotic Stop Policy for Adults

• Trust policy for reducing harm from omitted and delayed critical medicines

• Policy or service being assessed:Management of Acute Kidney Injury (AKI) in Adults

• Policy or service being assessed: Monitoring gentamicin levels on the neonatal unit

• Policy for Developing Trust Documents (Policy of Policies)

• Trust Policy for Management of Linen

• Trust Guideline for Intravenous Phenytoin Administration in Adults

• Trust Guideline for Dabigatran for the Prevention of Stroke and Systemic Embolism in Patients with Non ValvularAF
• Trust Guideline for Rivaroxaban for the Prevention of Stroke and System Embolism in Patients with Non Valvular AF and for the Treatment of DVT and PE, and the Prevention of Recurrent DVT and PE in adults

• Trust Guideline for the Management of Bleeding in Patients taking Treatment Doses of a NOAC

• Policy or service being assessed: Re-organisation of the Linen Services Department and the Contract Monitoring Department

• Trust Guideline for Ciclosporin Treatment and Monitoring for Patients with Acute Severe Ulcerative Colitis

• Trust Guideline for the management of DKA in adults

• Trust Policy for Domestic Abuse Version 2

• Trust Policy for Homecare Medicine Services

Trust Policy for Blood Culture Collection

Policy or service being assessed: Suspected Congenital Heart Disease

Policy or service being assessed: Trust Guideline for Vapotherm (HFNC)

Trust Guideline for Enteral Tubes

Policy orservice being assessed: Children’s Chronic Fatigue service changing base from the Lister to the QEII

Trust Policy for Infection Prevention & Control Issues for Staff Health

Trust Policy for Animals in Hospital

Trust Policy for Cleaning and Disinfection for Ophthalmic Equipment in contact with the Anterior Eye

RustIsolation Policy

Trust Policy for Norovirus – Infection Control Management of Gastroenteritis known or suspected to be caused by Norovirus

Trust Policy for Transmissible Spongiform Encephalopathy

Trust Guideline for The Infection Prevention & Control Management of Chickenpox and Shingles (Varicella-zoster Virus)

Trust Guideline for Risk assessment and Prevention of Venous Thromboembolism (VTE) in adults (including women attending Obstetric Clinics).

Trust Guideline forthe use of Phosphate.

Trust Policy for Chaperoning Intimate consultations, examinations, investigations and chaperoning

• Trust Guideline for Management of Oral Anticoagulation.

• Trust Guideline for Standard Heparin Infusion Schedule for Full Anticoagulation

Trust Policy and Guidelines on Giving Employment References

• Trust Policy for Resuscitation
• Trust Policy for Appraisal
• Trust Policy for Consent